DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. 1996

H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
Department of Pathology, National Institute of Health, Toyama, Shinjuku-ku, Tokyo, Japan.

CRK belongs to a family of adaptor proteins that consist mostly of SH2 and SH3 domains. Far Western blotting with CRK SH3 has demonstrated that it binds to 135- to 145-, 160-, and 180-kDa proteins. The 135- to 145-kDa protein is C3G, a CRK SH3-binding guanine nucleotide exchange protein. Here, we report on the molecular cloning of the 180-kDa protein, which is designated DOCK180 (180-kDa protein downstream of CRK). The isolated cDNA contains a 5,598-bp open reading frame encoding an 1,866-amino-acid protein. The deduced amino acid sequence did not reveal any significant homology to known proteins, except that an SH3 domain was identified at its amino terminus. To examine the function of DOCK180, a Ki-Ras farnesylation signal was fused to the carboxyl terminus of DOCK180, a strategy that has been employed successfully for activation of adaptor-binding proteins in vivo. Whereas wild-type DOCK180 accumulated diffusely in the cytoplasm and did not have any effect on cell morphology, farnesylated DOCK180 was localized on the cytoplasmic membrane and changed spindle 3T3 cells to flat, polygonal cells. These results suggest that DOCK180 is a new effector molecule which transduces signals from tyrosine kinases through the CRK adaptor protein.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
November 1998, Genes & development,
H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
April 1998, Oncogene,
H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
February 2001, The Biochemical journal,
H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
August 2008, The Journal of cell biology,
H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
January 2012, PloS one,
H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
January 2010, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
May 2013, Biochemical and biophysical research communications,
H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
May 2012, Biochemistry,
H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
April 2016, Viruses,
H Hasegawa, and E Kiyokawa, and S Tanaka, and K Nagashima, and N Gotoh, and M Shibuya, and T Kurata, and M Matsuda
July 2006, Journal of cellular biochemistry,
Copied contents to your clipboard!